BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6529114)

  • 1. [The reaction of antibody-dependent cell-mediated cytotoxicity (ADCC)].
    Hanton G; Pastoret PP
    Ann Rech Vet; 1984; 15(4):443-54. PubMed ID: 6529114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virus-induced enhancement of lymphocyte-mediated antibody-dependent cytotoxicity (ADCC) in vitro.
    Alsheikhly AR; Wåhlin B; Andersson T; Perlmann P
    J Immunol; 1984 Jun; 132(6):2760-6. PubMed ID: 6373918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK; Saxena QB; Adler WH
    Immunology; 1982 Jun; 46(2):459-64. PubMed ID: 7084998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes: a regulatory role for the sheep red blood cell receptor.
    Fuson EW; Cole AJ; Hubbard RA
    J Clin Lab Immunol; 1985 Aug; 17(4):183-9. PubMed ID: 2999410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).
    Sato N; Yabuki Y; Toh K; Ishii Y; Kikuchi K
    Immunology; 1979 Mar; 36(3):421-6. PubMed ID: 437836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human antibody-dependent cellular cytotoxicity, cell-mediated cytotoxicity, and natural killing by a xenogeneic antiserum prepared against "activated" alloimmune human lymphocytes.
    Neville ME; Hiserodt JC
    J Immunol; 1982 Mar; 128(3):1246-51. PubMed ID: 6976989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
    Kumagai S; Steinberg AD; Green I
    J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between antibody-dependent cell-mediated cytotoxicity due to anti-HTLV-1 and negative signal of major histocompatibility complex class I antigens on adult T-cell leukemia cell lines.
    Komatsu F; Tamiya H
    Oncol Res; 1998; 10(2):59-67. PubMed ID: 9666513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
    Christiaansen JE; Sears DW
    Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibody-dependent cell-mediated cytotoxic reaction. II. The effect of the concentration of anti-target cell antibodies on the identity of the human effector cells.
    Keaney M; McPhail S; Jodouín CA; Richter M
    Immunology; 1980 Jun; 40(2):205-10. PubMed ID: 7409857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibody-dependent cell-mediated immune reactions--fundamentals and clinico-diagnostic relevance (author's transl)].
    Groth J; Kaden J
    Allerg Immunol (Leipz); 1980; 26(2):111-26. PubMed ID: 6449839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct functions of surface receptors in the induction of neutrophil-mediated cytotoxicity.
    Cordier G; Samarut C; Revillard JP
    Ann Immunol (Paris); 1981; 132D(1):3-14. PubMed ID: 7347555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens II. Induction of ADCC by FC-FC receptor bridging.
    Jondal M
    Clin Exp Immunol; 1977 Jul; 29(1):1-10. PubMed ID: 196801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antibody-independent cytotoxic activity of normal circulating human leucocytes. I. Lysis of target cells by monocytes and neutrophils in a non-phagocytic pathway.
    Banerjee D; Fernando L; Sklar S; Richter M
    Immunology; 1981 Sep; 44(1):97-107. PubMed ID: 7275189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effector cells in avian spontaneous and antibody-dependent cell-mediated cytotoxicity.
    Fleischer B
    J Immunol; 1980 Sep; 125(3):1161-6. PubMed ID: 7410832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.